Open Access

E. Papatheodorou, D. Degiannis, A. Anastasakis

2022.2.4Cardiogenetics

DOI: 10.3390/cardiogenetics12010006

tlooto Summary

The latest evidence regarding the role of genetics in patients with HTAD is presented and evolving phenotype–genotype correlations lead us towards more precise and individualized management and treatment of patients withHTAD.

Abstract

Genetic testing plays an increasing diagnostic and prognostic role in the management of patients with heritable thoracic aortic disease (HTAD). The identification of a specific variant can establish or confirm the diagnosis of syndromic HTAD, dictate extensive evaluation of the arterial tree in HTAD with known distal vasculature involvement and justify closer follow-up and earlier surgical intervention in HTAD with high risk of dissection of minimal or normal aortic size. Evolving phenotype–genotype correlations lead us towards more precise and individualized management and treatment of patients with HTAD. In this review, we present the latest evidence regarding the role of genetics in patients with HTAD.

Citation format

PAPATHEODOROU, E.; DEGIANNIS, D.; ANASTASAKIS, A. Genetics of heritable thoracic aortic disease. Cardiogenetics, 2022.